We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-1.06 | -1.88% | 55.25 | 56.74 | 53.70 | 56.39 | 37,885,347 | 00:59:31 |
Date of Report (Date of earliest event reported):
|
June 10, 2020
|
Delaware
|
001-01011
|
05-0494040
|
(State or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, par value $0.01 per share
|
CVS
|
New York Stock Exchange
|
Emerging growth company
|
☐
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
☐
|
(1)
|
The Company defines adjusted income attributable to CVS Health as net income attributable to CVS Health (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance, such as acquisition-related integration costs, the corresponding income tax benefit or expense related to the items excluded from adjusted income attributable to CVS Health, and any other items specifically identified herein. GAAP diluted EPS and Adjusted EPS, respectively, are calculated by dividing net income attributable to CVS Health and adjusted income attributable to CVS Health by the Company’s weighted average diluted shares outstanding. The following table reconciles projected GAAP diluted EPS to projected Adjusted EPS:
|
|
|
Year Ending December 31, 2020
|
||||||
|
|
Per Common Share
|
||||||
|
|
Low
|
|
High
|
||||
Net income attributable to CVS Health (GAAP measure)
|
|
$
|
5.47
|
|
|
$
|
5.60
|
|
Non-GAAP adjustments:
|
|
|
|
|
||||
Amortization of intangible assets
|
|
1.76
|
|
|
1.76
|
|
||
Acquisition-related integration costs
|
|
0.34
|
|
|
0.34
|
|
||
Income tax benefit
|
|
(0.53
|
)
|
|
(0.53
|
)
|
||
Adjusted income attributable to CVS Health
|
|
$
|
7.04
|
|
|
$
|
7.17
|
|
|
|
|
|
|
||||
Weighted average diluted shares outstanding (in millions)
|
|
1,320
|
|
|
1,320
|
|
|
|
|
|
104
|
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
CVS HEALTH CORPORATION
|
|
|
|
Date: June 10, 2020
|
By:
|
/s/ Eva C. Boratto
|
|
|
Eva C. Boratto
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions